![Jason Gross](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jason Gross
Technik-/Wissenschafts-/F&E-Leiter bei
HLS THERAPEUTICS INC.
Vermögen: 148 106 $ am 31.07.2026
Profil
Jason A. Gross is currently Vice President-Scientific Affairs at HLS Therapeutics, Inc., a position held since 2014.
Former roles include Vice President-Scientific & Medical Affairs at Cipher Pharmaceuticals, Inc. from 2012 to 2013, Vice President at Lumira Capital Investment Management, Inc., VP-Scientific & Medical Affairs at IVAX Pharmaceuticals, Inc., VP-Regulatory Affairs & Quality Assurance at Drugabuse Sciences, Inc., and Vice President-Scientific Affairs at HLS Therapeutics, Inc. Education includes a doctorate from the University of Arizona.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
HLS THERAPEUTICS, INC. 0,16 % | 26.06.2026 | 49 700 ( 0,16 % ) | 148 106 $ | 31.07.2026 |
Aktive Positionen von Jason Gross
| Unternehmen | Position | Beginn |
|---|---|---|
| HLS THERAPEUTICS INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2014 |
Ehemalige bekannte Positionen von Jason Gross
| Unternehmen | Position | Ende |
|---|---|---|
Lumira Capital Investment Management, Inc.
 Lumira Capital Investment Management, Inc. Investment ManagersFinance LUMIRA invests in revenue stage companies that are both privately held and publically traded companies located in the Canada and the United States. The firm focuses on sectors of therapeutic products and medical devices. It participates in the early stage capital financing. | Private Equity Investor | 31.03.2006 |
HLS Therapeutics, Inc. /Old/
 HLS Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Provides specialty pharmaceutical products | Corporate Officer/Principal | - |
IVAX Pharmaceuticals, Inc.
 IVAX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical products | Technik-/Wissenschafts-/F&E-Leiter | - |
Drugabuse Sciences, Inc. | General Counsel | - |
| CIPHER PHARMACEUTICALS INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Jason Gross
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
25
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Cipher Pharmaceuticals, Inc.
 Cipher Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Provides laboratory testing and medical imaging services | Health Technology |
Lumira Capital Investment Management, Inc.
Lumira Capital Investment Management, Inc. Investment ManagersFinance LUMIRA invests in revenue stage companies that are both privately held and publically traded companies located in the Canada and the United States. The firm focuses on sectors of therapeutic products and medical devices. It participates in the early stage capital financing. | Finance |
University of Arizona
 University of Arizona Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IVAX Pharmaceuticals, Inc.
IVAX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical products | Health Technology |
Drugabuse Sciences, Inc. | |
HLS Therapeutics, Inc. /Old/
HLS Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Provides specialty pharmaceutical products | Health Technology |
HLS Therapeutics, Inc.
 HLS Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
